HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

890.408

-22.370-2.45%

Number of Gainers:1

Number of Losers:16

Number of Flat:- -

PE:- -

High:911.751

Open:911.751

Low:887.660

Close:912.778

Volume:390.86M

Turnover:2.96B

Market Cap:600.58B

Float Cap:498.11B

Loading ...

Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors

BYD Electronic (International) Stock Advances 6.8% in Hong Kong

Ascletis Pharma Joins Two Chinese Stock Connect Programs

MT Newswires Live

Kintor Pharma Shares Rise as Skin Tone Treatment Inches Closer to Approval After Trial Results

MT Newswires Live

Fosun Pharmaceutical Extends Deadline of 81 Million Yuan Shareholder Loans to Fuyun Health; Shares Up 7%

MT Newswires Live

Ascletis Announces Inclusion in the Hong Kong Stock Connect List Under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs

THOMSON REUTERS

UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts

ALEBUND-B Announced H Shares Inclusion in Stock Connect and Hang Seng Composite Index

AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets

Kintor Pharma Completes 52-Week Human Safety Trial of Skin-Whitening Ingredient KT-939

Chinese Automakers Shift Toward Deep Overseas Expansion With Local Manufacturing and Dealer Networks

Shanghai Fosun Pharma 2196.hk Says it Plans to Buy Back up to HK$1Bln of Company H-Shares

THOMSON REUTERS

Fosun Pharma's Unit to Trim Stake in Gland Pharma via Share Sale

Dizhe Pharma Stock Drops Over 5% After Insider Sell-Off Plan; Company Affirms Long-Term Confidence

ALEBUND-B (09637) H Shares Set to Join Stock Connect and Hang Seng Composite Index

Wuhan Dazhong Dental Proposes Wang Hong as Executive Director to Replace Guo Jiaping

Junshi Biosciences Schedules 2026 Interim Results Conference Call

Traditional Chinese Medicine Firm Secures Regulatory Approval for New Depression Treatment

China Traditional Chinese Medicine Says NMPA Approves Launch of Xingpi Jieyu Tablets for Depression

China Traditional Chinese Medicine Holdings - Nmpa Approves Xingpi Jieyu Tablets for Marketing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BK1515/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":890.4082,"timestamp":1789027721934,"preClose":912.77844,"halted":0,"volume":390861706,"delay":0,"changeRate":-0.024508,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-22.370239,"latestTime":"09-10 16:00:00","open":911.75104,"high":911.75104,"low":887.6602,"amount":2960733819,"amplitude":0.026393,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"pbRate":1.367616,"peRate":17.723048,"turnoverRate":0.005102,"increases":1,"decrements":16,"flats":0,"marketCap":600577450304,"floatMarketCap":498112716352},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":911.75104,"amplitude":0.026393,"preClose":912.77844,"low":887.6602,"pbRate":"1.367616","latestPrice":890.4082,"volume":390861706,"delay":0,"open":911.75104,"prevYearClose":1190.107,"prevWeekClose":936.431,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":925.365,"twentyDayClose":923.05,"sixtyDayClose":869.522,"secType":"PLATE","market":"HK","turnoverRate":0.005102,"peRate":17.723048,"marketCap":600577450304,"floatMarketCap":498112716352,"timestamp":1789027721934,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":1,"down":16,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665739003","title":"Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665739003","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665739003?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:32","pubTimestamp":1788769920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.2% to 5.47 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 40% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.1% and Amgen Inc. remained unchanged.Trading volume totaled 42.8 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU2112291526.USD","IE00BZ08YS42.EUR","IBB","BBH","IE0002141913.USD","IE00BZ08YT58.USD","HK0000165453.HKD","LU2242652126.USD","BK1515","IE00B2B36J28.USD","BIB","LU1057294990.SGD","LU1571399168.USD","PJP","01177","LU0109394709.USD","LU1983299246.USD","LU2242646821.SGD","LU0889565916.HKD","LU1023059063.AUD","SG9999001440.SGD","IBBQ","BK4533","BK4599","LU0289739699.SGD","BK1589","BK4588","LU2468319806.SGD","BK4566","LU0868494617.USD","LU0122379950.USD","BK1521","BK1191","AMGN","LU0320765992.SGD","LU0058720904.USD","IE0009355771.USD","TBXU","BK4534","IE00BZ08YR35.GBP","LU1061106388.HKD","IE00BJT1NW94.SGD","PBE","LU2089984988.USD","BK4585","IE00BFTCPJ56.SGD","BK4581","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390776","title":"BYD Electronic (International) Stock Advances 6.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390776","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665390776?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:30","pubTimestamp":1788769800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of BYD Electronic  Co. Ltd. rallied 6.8% to 26.88 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's second consecutive day of gains.BYD Electronic  Co. Ltd. closed 40% below its 52-week high of HK$44.60, which the company reached Oct. 2.The stock outperformed some of its competitors, as Times Universal Group Holdings Ltd. remained unchanged.Trading volume totaled 19.6 million shares, compared to the 50-day average of 12.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1580","BK1607","LU0348767384.USD","BK1504","BK1149","BK1515","BK1589","LU0348766576.USD","LU0274383008.USD","BK1167","BK1540","00285","BK1582"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665474394","title":"Ascletis Pharma Joins Two Chinese Stock Connect Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665474394","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665474394?lang=en_us&edition=fundamental","pubTime":"2026-09-07 14:34","pubTimestamp":1788762852,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  said it has been included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective Sept. 7.The inclusion allows mainland Chinese investors to trade the biotech company's Hong Kong-listed shares through the Stock Connect platform, according to a Monday Hong Kong bourse filing.Shares of the drugmaker rose over 2% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02823","BK1515","KWEB","82822","02822","02843","ASHS","XPP","KCAI","FLCH","YXI","BK1161","CHAU","CWEB","YINN","KBA","BK1574","YANG","FXP","82823","01672","ASHR","82843"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665992903","title":"Kintor Pharma Shares Rise as Skin Tone Treatment Inches Closer to Approval After Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665992903","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665992903?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:11","pubTimestamp":1788757872,"startTime":"0","endTime":"0","summary":"Kintor Pharmaceutical  has disclosed positive results from the long-term safety trial of its skin tone correcting treatment, KT-939, according to a Monday bourse filing.Preliminary data showed that KT-939 was safe and well-tolerated, and participants treated with it for about a year did not experience any adverse skin reactions, the company said.Kintor said it is now working to advance KT-939's registration application for approval by the National Medical Products Administration before launching it commercially.The company's shares are up 5.5% in midday trading on the HKEX.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","BK1515","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665992823","title":"Fosun Pharmaceutical Extends Deadline of 81 Million Yuan Shareholder Loans to Fuyun Health; Shares Up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665992823","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665992823?lang=en_us&edition=fundamental","pubTime":"2026-09-07 13:05","pubTimestamp":1788757530,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical , along with its controlling shareholder and subsidiaries, agreed to extend the shareholder loans worth 80.8 million yuan provided to Fuyun Health for another year, according to a Shanghai bourse filing over the weekend.The Chinese pharmaceutical company's Hong Kong shares jumped 7%, while Shanghai shares rose 1% during Monday's midday trade.The loans' extended maturity date will be Sept. 4, 2027, and the annual interest rate during the extension period will remain at 3.2%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK0028","BK0188","02196","BK0012","BK0183","BK1593","BK0060","BK0096","BK0175","BK0187","600196","BK0239","BK1515","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399806","title":"Ascletis Announces Inclusion in the Hong Kong Stock Connect List Under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399806","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399806?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:15","pubTimestamp":1788754501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nTUABQ4B5D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01672","BK1515","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109390642","title":"UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1109390642","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109390642?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:50","pubTimestamp":1788745830,"startTime":"0","endTime":"0","summary":"UBS has released a research note suggesting that while market expectations for the Chinese biotech sector's first-half results were initially conservative—due to concerns over tighter domestic drug...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516571.SGD","LU2328871848.SGD","LU0417516902.SGD","LU1303224171.USD","KURE","LU0561508036.HKD","LU0348735423.USD","BK4139","BK1587","BK1500","HK0000165453.HKD","LU0348784397.USD","BK4588","LU2097828557.USD","LU0244354667.USD","LU0634319403.HKD","01801","BK1588","LU0348827113.USD","BK1515","BK1589","03069","00013","IE00BPRC5H50.USD","LU0326950275.SGD","ONC","LU1770034418.SGD","LU0228659784.USD","LU0196878994.USD","BK4526","01877","09969","LU0348825331.USD","LU0417516738.SGD","LU0588546209.SGD","LU2476274308.USD","LU1794554557.SGD","688235","LU0348767384.USD","BK1574","LU0463099449.HKD","LU2097828474.EUR","BK1583","LU0455707207.USD","LU2399975544.HKD","LU0307460666.USD","LU1720050803.USD","BK1191","IE00B543WZ88.USD","LU1969619763.USD","06990","LU2476274720.SGD","LU0348766576.USD","LU2097828714.EUR","LU2097828631.EUR","LU1961090484.USD","BK4585","LU0502904849.HKD","LU1251922891.USD","LU1719994722.HKD","06160","LU0348783233.USD","LU0540923850.HKD","IE00B5MMRT66.SGD","LU0828237510.HKD","09926","BK0239","LU2488822045.USD","LU2778985437.USD","LU1188198961.HKD","LU2097828805.USD","BK1161","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187807186","title":"ALEBUND-B Announced H Shares Inclusion in Stock Connect and Hang Seng Composite Index","url":"https://stock-news.laohu8.com/highlight/detail?id=1187807186","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187807186?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:00","pubTimestamp":1788742832,"startTime":"0","endTime":"0","summary":"ALEBUND-B (09637) has announced that, in accordance with the relevant arrangements and adjustments for Stock Connect, its H shares have been included in the list of eligible securities for Stock...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1191","09939","BK1574","BK1515","FLHK","159938","HSCI","09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184969761","title":"AI-Powered Drug Discovery Heats Up as Innovative Medicines Race Accelerates in Hong Kong Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=1184969761","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184969761?lang=en_us&edition=fundamental","pubTime":"2026-09-07 07:02","pubTimestamp":1788735760,"startTime":"0","endTime":"0","summary":"The innovative medicine sector is gaining significant momentum as artificial intelligence transforms the drug development landscape from discovery through clinical trials and regulatory approval. A...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1191","BK4588","VTHR","VXUS","BK1515","KCAI","BK1574","BK1617","MEDX","02228","06978","159992","CHAT","BK1141","AIPO","IBBQ","BK1593","QTOC","BK1161","AGIX","ARTY","02196","BK4585","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665438367","title":"Kintor Pharma Completes 52-Week Human Safety Trial of Skin-Whitening Ingredient KT-939","url":"https://stock-news.laohu8.com/highlight/detail?id=2665438367","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665438367?lang=en_us&edition=fundamental","pubTime":"2026-09-07 06:08","pubTimestamp":1788732492,"startTime":"0","endTime":"0","summary":"Kintor Pharma completes 52-week human safety trial of skin-whitening ingredient KT-939Kintor Pharmaceutical completed a 52-week long-term human safety trial of KT-939 on Sept. 4, 2026.Preliminary resu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260906:nNDL4qRNq1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115611725","title":"Chinese Automakers Shift Toward Deep Overseas Expansion With Local Manufacturing and Dealer Networks","url":"https://stock-news.laohu8.com/highlight/detail?id=1115611725","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115611725?lang=en_us&edition=fundamental","pubTime":"2026-09-06 19:51","pubTimestamp":1788695476,"startTime":"0","endTime":"0","summary":"Cui Dongshu, secretary general of the China Passenger Car Association, noted that drawing on lessons from the home appliance industry's international expansion, Chinese automakers have developed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0543330566.HKD","LU0084288322.USD","LU0979878070.USD","LU0175139822.USD","BK0183","LU2357125470.USD","BK0264","LU0593848301.USD","BK1582","BK1539","EVS.SI","LU0289960550.SGD","LU0588545490.SGD","LU0348827113.USD","LU0865486749.SGD","LU0052750758.USD","LU1242518931.SGD","LU1997245094.SGD","LU0229945570.USD","LU1188198961.HKD","LU0348805143.USD","BK1540","LU1861219969.SGD","LU0683595622.HKD","FDRV","LU0211977185.USD","LU1861214812.USD","LU0326950275.SGD","LU0588545904.SGD","LU0039217434.USD","LU0561508036.HKD","LU0054450605.USD","LU0516422952.EUR","LU0594300419.USD","LU0823414551.USD","SG9999015952.SGD","LU0516423174.USD","LU1580142542.USD","LU0594300179.USD","LU1770034418.SGD","LU2289578879.USD","LU2506951792.HKD","BK1607","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","SG9999001226.SGD","LU0634319403.HKD","FSXEmain","LU0164872284.USD","LU0708995153.HKD","SG9999015978.USD","LU0165289439.USD","LU0516422440.USD","LU0469268626.HKD","LU0143863784.USD","LU0251144936.SGD","LU0289739343.SGD","LU1880383366.USD","LU1808992512.USD","LU0320764599.SGD","LU2476274308.USD","BK0155","LU0359201612.USD","BK1149","BK0072","BK1504","LU0214875030.USD","LU2097828714.EUR","SG9999014674.SGD","LU0509642566.USD","LU2476274720.SGD","LU2328871848.SGD","LU2148510915.USD","LU0449515922.USD","SG9999002828.SGD","LU0348825331.USD","BK1594","LU0531970944.HKD","LU0819121731.USD","IE00BD6J9T35.USD","IE00BZ08YR35.GBP","BK1610","00285","LU0588545730.USD","LU1146622755.USD","LU0819123356.HKD","LU0417516902.SGD","LU0307460666.USD","LU0359202008.SGD","LU0359201885.HKD","LU0289961442.SGD","SG9999006597.SGD","LU0540923850.HKD","BK0188","01211","LU0823414478.USD","LU0511384066.AUD","LU0856984785.SGD","LU0871576103.HKD","002594","LU1508157978.USD","LU1820825898.SGD","LU1880383440.USD","LU0828238088.HKD","LU0269904917.USD","LU1242518857.USD","LU0128522744.USD","BK1580","LU1023057109.AUD","LU2294711713.HKD","LU2580892789.USD","LU0254981946.USD","LU0320764243.SGD","HYDD.SI","BK1167","LU0348766576.USD","LU0633140560.USD","LU0708995583.HKD","LU1251922891.USD","LU0259732245.USD","LU0463099449.HKD","LU1064131003.USD","LU0516422366.SGD","LU1720050803.USD","LU1328277881.USD","BK1589","LU0823426308.USD","LU0143863198.USD","LU2580892862.HKD","LU0531971595.HKD","BK0196","BK0169","LU0516423091.SGD","LU2039709279.SGD","SG9999002463.SGD","LU0572944931.SGD","LU0043850808.USD","LU2360107325.USD","LU0274383008.USD","BK1119","LU2097828474.EUR","LU0633140727.USD","LU0327786744.USD","BK1509","SG9999015986.USD","BK0070","LU0314109678.HKD","LU0348767384.USD","LU1997245177.USD","81211","LU2449936058.SGD","LU2348774022.SGD","BYDDY","BK1522","LU0244354667.USD","LU0315178854.USD","BK0014","LU1868837722.USD","LU0823038988.USD","LU0261947096.USD","LU0348735423.USD","LU1813983027.USD","LU1961090484.USD","LU2495084118.USD","LU2097828557.USD","LU1064130708.USD","LU1868837565.USD","LU0029874905.USD","LU0823426480.USD","LU0505663152.USD","LU2153592121.USD","LU0650527681.SGD","LU0417516738.SGD","LU1719994722.HKD","BK1515","LU0823039010.USD","LU1781817850.SGD","LU2097828805.USD","LU1969619763.USD","LU2249611893.SGD","LU0449509016.USD","SMOG","LU2097828631.EUR","SG9999015945.SGD","LU0605514214.HKD","LU0048597586.USD","SG9999006514.SGD","LU1303224171.USD","LU1997244956.HKD","LU2778985437.USD","LU1794554557.SGD","LU2663582299.SGD","LU0588546209.SGD","LU0164865239.USD","LU2399975544.HKD","LU1868838027.USD","FESXmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665364504","title":"Shanghai Fosun Pharma 2196.hk Says it Plans to Buy Back up to HK$1Bln of Company H-Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665364504","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665364504?lang=en_us&edition=fundamental","pubTime":"2026-09-06 18:34","pubTimestamp":1788690846,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260906:nL6N44Y02K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","600196","BK0060","BK0012","BK0187","BK0188","BK0196","BK1191","02196","BK0096","BK0183","BK1515","BK0028","BK0239","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120592433","title":"Fosun Pharma's Unit to Trim Stake in Gland Pharma via Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=1120592433","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120592433?lang=en_us&edition=fundamental","pubTime":"2026-09-06 17:04","pubTimestamp":1788685454,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SH) has announced that its controlling subsidiary, Fosun Pharma Singapore, executed a share sale of Gland Pharma shares on September 4, 2026...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1191","BK0175","BK0012","BK0096","BK0060","BK0239","BK1593","BK0028","600196","BK0196","BK0183","BK0188","BK0187","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129259024","title":"Dizhe Pharma Stock Drops Over 5% After Insider Sell-Off Plan; Company Affirms Long-Term Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1129259024","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129259024?lang=en_us&edition=fundamental","pubTime":"2026-09-06 15:11","pubTimestamp":1788678679,"startTime":"0","endTime":"0","summary":"Dizhe Pharma (also known as Dizhe Pharmaceutical) saw its share price tumble more than 5% on Thursday, September 4th, following a disclosure that four senior executives plan to reduce their holdings...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","159938","BK1574","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144923293","title":"ALEBUND-B (09637) H Shares Set to Join Stock Connect and Hang Seng Composite Index","url":"https://stock-news.laohu8.com/highlight/detail?id=1144923293","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144923293?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:36","pubTimestamp":1788528973,"startTime":"0","endTime":"0","summary":"The Board of ALEBUND-B (09637) has announced that its H shares have been included in the list of eligible securities under the Stock Connect programme. This inclusion will take effect from Monday,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","159938","HSCI","FLHK","BK1161","09637","BK1191","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664204332","title":"Wuhan Dazhong Dental Proposes Wang Hong as Executive Director to Replace Guo Jiaping","url":"https://stock-news.laohu8.com/highlight/detail?id=2664204332","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664204332?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:30","pubTimestamp":1788528637,"startTime":"0","endTime":"0","summary":"Wuhan Dazhong Dental proposes Wang Hong as executive director to replace Guo JiapingWuhan Dazhong Dental Medical proposed appointing vice general manager Wang Hong as an executive director, pending sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDLbWh1cr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","FTXH","IE0002141913.USD","IE00BZ08YR35.GBP","LU1894683264.USD","LU1057294990.SGD","LU2756315664.SGD","LU0792757196.USD","BK1515","FHLC","LU1732799900.SGD","PJP","RXL","IXJ","LU0820562030.AUD","LU1894683348.USD","LU0234572021.USD","LU0345769128.USD","JNJ","BMED","IE000MB6IJN5.SGD","IE00BLSP4239.USD","SG9999001440.SGD","XLV","LU2750360997.AUD","LU0964807845.USD","LU2592432038.USD","TRUH","LU0058720904.USD","LU2471134523.USD","VHT","LU2430703251.USD","LU0820561909.HKD","LU0912757837.SGD","LU1244550577.SGD","IE00B3T34201.USD","LU1066051498.USD","LU0053666078.USD","LU2430703178.SGD","IYH","LU1929549753.HKD","GDOC","LU1551013342.USD","LU1061106388.HKD","01177","MEDX","JDOC","02651","LU0943347566.SGD","IE00BDGV0183.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185361801","title":"Junshi Biosciences Schedules 2026 Interim Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=1185361801","media":"Deep News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185361801?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:13","pubTimestamp":1788527603,"startTime":"0","endTime":"0","summary":"Junshi Biosciences (also known as JUNSHI BIO) has announced it will hold a conference call to discuss its 2026 interim financial results on September 14, 2026.According to the company's latest...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877","BK1161","BK1515","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103371342","title":"Traditional Chinese Medicine Firm Secures Regulatory Approval for New Depression Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1103371342","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103371342?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:54","pubTimestamp":1788526459,"startTime":"0","endTime":"0","summary":"TRAD CHI MED (00570) has announced that its subsidiary, Guizhou Tongjitang Pharmaceutical Co., Ltd., has received official market authorization from the National Medical Products Administration...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK1574","IPOS","MEDX","LNGR","159992","BK1161","06978","BK1191","00570","BK1515","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664334921","title":"China Traditional Chinese Medicine Says NMPA Approves Launch of Xingpi Jieyu Tablets for Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2664334921","media":"Reuters","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664334921?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:46","pubTimestamp":1788525998,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine says NMPA approves launch of Xingpi Jieyu tablets for depressionChina Traditional Chinese Medicine Holdings said China’s NMPA cleared its Class 1.1 TCM innovative dr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL6dF7Rm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1515","00570","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664349413","title":"China Traditional Chinese Medicine Holdings - Nmpa Approves Xingpi Jieyu Tablets for Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664349413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664349413?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:46","pubTimestamp":1788525987,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nFWN44W0SO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00570","BK1515","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}